Nuvation Bio, Inc. (NUVB)
5.85
-0.29
(-4.72%)
USD |
NYSE |
Jan 16, 16:00
5.85
0.00 (0.00%)
Pre-Market: 20:00
Nuvation Bio Total Liabilities (Quarterly): 275.68M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Indivior PLC | 1.623B |
| Terns Pharmaceuticals, Inc. | 17.58M |
| GRAIL, Inc. | 361.07M |
| Arrowhead Pharmaceuticals, Inc. | 947.02M |
| Corcept Therapeutics, Inc. | 191.70M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 601.56M |
| Shareholders Equity (Quarterly) | 325.88M |
| Debt to Equity Ratio | 0.6387 |
| Current Ratio | 8.477 |
| Net Debt Paydown Yield | 1.28% |